K Number
K213848
Date Cleared
2022-03-25

(105 days)

Product Code
Regulation Number
880.6250
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Medical nitrile examination gloves is intended to be worn on the hands of examiners to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

Device Description

The subject device is a powder-free nitrile examination glove, provided as a non-sterile and disposable device. The subject device is mainly made from nitrile and there are four sizes, including small (S), medium (M), large (L), X-large (XL) for optional. The gloves are provided with blue color, the colorant is Pigment Blue (CAS No.147-14-8). The examination glove is a smooth surface and has a rolled rim at the cuff edge.

AI/ML Overview

Here's a breakdown of the acceptance criteria and the study information for the Medical Nitrile Examination Gloves (Model: JL001), based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Test MethodTest PurposeAcceptance CriteriaReported Device PerformanceConclusion
ASTM D6319-19 (Physical Dimensions)To determine the width, length, and thickness of the glovesWidth:For S: 80±10 mmFor M: 95±10 mmFor L: 110±10 mmFor XL: 120±10 mmLength:For S: ≥220mmFor M/L/XL: ≥230mmFinger Thickness: min. 0.05 mmPalm Thickness: min. 0.05 mmLot Batch 20210716A:Width: S: 7983mm, M: 9397mm, L: 101-105mm, XL: 110mmLength: S: 233237mm, M: 233237mm, L: 240244mm, XL: 240244mmThickness: Finger min: 0.12mm, Palm min: 0.08mmLot Batch 20210719A:Width: S: 7983mm, M: 9497mm, L: 101-104mm, XL: 110mmLength: S: 234236mm, M: 234237mm, L: 240244mm, XL: 240245mmThickness: Finger min: 0.13mm, Palm min: 0.08mmLot Batch 20210721C:Width: S: 8085mm, M: 9498mm, L: 105-109mm, XL: 110mmLength: S: 230235mm, M: 235238mm, L: 239243mm, XL: 240243mmThickness: Finger min: 0.13mm, Palm min: 0.08mmPassed
ASTM D6319-19 (Physical Properties)To determine the tensile strength and ultimate elongation before and after acceleration agingBefore Aging:Tensile Strength: ≥14MpaUltimate Elongation: ≥500%After Aging:Tensile Strength: ≥14MpaUltimate Elongation: ≥400%For all three lots:Before Aging: Tensile Strength: ≥14Mpa, Ultimate Elongation: ≥500%After Aging: Tensile Strength: ≥14Mpa, Ultimate Elongation: ≥400%Passed
ASTM D6319-19 (ASTM D5151-11) (Freedom from Holes)To determine the holes in the glovesAQL 2.5For all three lots: Pass at AQL 2.5Passed
ASTM D6319-19 (ASTM D6124-11) (Residual Powder)To determine the residual powder in the gloves< 2.0 mg/gloveLot Batch 20210716A: 0.12 mg/gloveLot Batch 20210719A: 0.15 mg/gloveLot Batch 20210721C: 0.21 mg/glovePassed
ISO 10993-10 (Skin Irritation)To evaluate the potential intracutaneous reactivity caused by intracutaneously inject the extract to rabbitsUnder the conditions of study not an irritationUnder the conditions of study not an irritationPassed
ISO 10993-10 (Skin Sensitization)To determine the skin sensitization potential in guinea pigsUnder the conditions of the study not a sensitizationUnder the conditions of the study not a sensitizationPassed
ISO 10993-11:2017 (Acute Systemic Toxicity)The test item was evaluated for acute systemic toxicity in ICR mouseUnder the conditions of the study no systemic toxicityUnder the condition of acute systemic toxicity test, the test article did not show acute systemic toxicity in vivo.Passed

2. Sample Size Used for the Test Set and Data Provenance

The document provides information on three lot batches used for non-clinical performance testing:

  • Lot Batch: 20210716A
  • Lot Batch: 20210719A
  • Lot Batch: 20210721C

The specific number of gloves sampled from each lot for each test (e.g., number of gloves for width/length, number of gloves for tensile strength, number of gloves for freedom from holes test to meet AQL 2.5) is not explicitly stated in the provided text. The data provenance is industrial testing of manufacturer's product, consistent with regulatory submissions for medical devices. The country of origin of the data is not explicitly stated, but the manufacturer is Guangdong Jiali Pharmaceutical Co.,Ltd in China.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

This information is not applicable as the document describes non-clinical performance testing (physical, chemical, and biocompatibility tests) of a medical device (nitrile examination gloves), not a study involving expert interpretation or medical imaging analysis. The "ground truth" for these tests is established by standardized laboratory methods and measurements according to ASTM and ISO standards.

4. Adjudication Method for the Test Set

This is not applicable as the study involves standardized physical and biocompatibility testing with objective pass/fail criteria, not subjective interpretations requiring adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No MRMC comparative effectiveness study was done. This type of study is relevant for diagnostic devices where human readers evaluate cases with and without AI assistance. This document describes the performance of examination gloves, which is not a diagnostic device.

6. Standalone Performance Study

Yes, a standalone study was done. The document focuses on the performance of the "Medical nitrile examination gloves" (JL001) itself against established international standards (ASTM and ISO). The device's performance was evaluated independently without human-in-the-loop interaction in a diagnostic sense.

7. Type of Ground Truth Used

The ground truth used for the non-clinical performance tests is based on established international standards and objective measurements:

  • For physical properties (width, length, thickness, tensile strength, elongation, residual powder, freedom from holes): Adherence to specific quantitative thresholds defined in ASTM D6319-19 and referenced standards like ASTM D5151-11 and ASTM D6124-11.
  • For biocompatibility: The biological response (irritation, sensitization, systemic toxicity) observed in animal models, evaluated against criteria defined in ISO 10993-10 and ISO 10993-11:2017.

8. Sample Size for the Training Set

This information is not applicable. The device described is a physical medical device (examination gloves), not an AI/ML algorithm. Therefore, there is no "training set" in the context of machine learning.

9. How the Ground Truth for the Training Set Was Established

This is not applicable for the same reason as point 8.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

March 25, 2022

Guangdong Jiali Pharmaceutical Co.,Ltd % Cassie Lee Manager Share Info (Guangzhou) Medical Consultant Ltd. No. 1919-1920. Building D3, Miniie Plaza, Shuixi Road, Huang District Guangzhou, Guangdong China

Re: K213848

Trade/Device Name: Medical nitrile examination gloves (Model: JL001) Regulation Number: 21 CFR 880.6250 Regulation Name: Non-Powdered Patient Examination Glove Regulatory Class: Class I, reserved Product Code: LZA Dated: February 14, 2022 Received: February 18, 2022

Dear Cassie Lee:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Bifeng Qian, M.D., Ph.D. Acting Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K213848

Device Name

Medical nitrile examination gloves (Model: JL001)

Indications for Use (Describe)

The Medical nitrile examination gloves is intended to be worn on the hands of examiners to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

Type of Use (Select one or both, as applicable)
-------------------------------------------------

Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary K213848

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 807.92.

1. Date of the summary prepared: March 15, 2022

2. Submitter's Information

Sponsor Name: Guangdong Jiali Pharmaceutical Co.,Ltd Address: Dawei, Niuqutian Villagers Committee, Muzhou Town, Xinhui, Jiangmen,Guangdong,China Post Code: 529143 Contact name: Jiali Chen Tel: +86-0750-3835982 Tel: +86-15988225228 E-mail: 275119024@gq.com

Application Correspondent:

Contact Person: Ms. Cassie Lee Company: Share Info (Guangzhou) Medical Consultant Ltd. Address: No. 1919-1920, Building D3, Minije Plaza, Shuixi Road, Huangpu District, Guangzhou, China Tel: +86 20 8200 6973 Email: regulatory@share-info.com

3. Subject Device Information

Type of 510(k): Traditional Common Name: Polymer Patient Examination Glove Classification Name: Non-powdered patient examination glove Trade Name: Medical nitrile examination qloves Model Name: JL001 Review Panel: General Hospital Product Code: LZA Requlation Number: 21 CFR 880.6250 Requlatory Class: Class I

4. Predicate Device Information

Sponsor: Guang Dong Kingfa SCI. & TECH.CO., LTD. Common Name: Polymer Patient Examination Glove

{4}------------------------------------------------

Classification Name: Non-Powdered Patient Examination Glove Trade Name: Patient Examination Gloves 510(k) Number: K203593 Review Panel: General Hospital Product Code: LZA Regulation Number: 21 CFR 880.6250 Regulatory Class: Class I

5. Device Description

The subject device is a powder-free nitrile examination glove, provided as a non-sterile and disposable device. The subject device is mainly made from nitrile and there are four sizes, including small (S), medium (M), large (L), X-large (XL) for optional. The gloves are provided with blue color, the colorant is Pigment Blue (CAS No.147-14-8). The examination glove is a smooth surface and has a rolled rim at the cuff edge.

6. Intended Use / Indications for Use

The Medical nitrile examination gloves is intended to be worn on the hands of examiners to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

7. Comparison to predicate device and conclusion
------------------------------------------------------
Elements ofComparisonSubject DevicePredicate DeviceResult
CompanyGuangdong Jiali PharmaceuticalCo.,LtdGuang Dong Kingfa SCI. &TECH.CO., LTD.--
510 (k) NumberK213848K203593--
Trade NameMedical nitrile examination glovesPatient Examination Gloves--
Product CodeLZALZA--
Classification NameNon-Powdered PatientExamination GloveNon-Powdered PatientExamination GloveSame
ClassificationClass IClass ISame
Regulation No.21 CFR 880.625021 CFR 880.6250Same
Indications For UseThe Medical nitrile examinationgloves is intended to be worn onthe hands of examiners toprevent contamination betweenpatient and examiner. This is aThe nitrile examination glove isintended to be worn on the handsof examiners to preventcontamination between patientand examiner. This is a single-Same
Elements ofComparisonSubject DevicePredicate DeviceResult
single-use, powder-free, non-sterile device.single-use, powder-free, non-sterile device.
Material of UseNitrile rubberNitrile rubberSame
ColorBlueBlueSame
TextureNoFinger TexturedDifferentNote
Size(ASTM D6319-19)Small, Medium, Large, X LargeSmall, Medium, Large, X LargeSame
SterilizationNon-sterileNon-sterileSame
UsageSingle usageSingle usageSame
Dimensions(ASTM D6319-19)Length:For S: ≥220 mmFor M/L/XL: ≥230 mmLength:S (220mm min)M (230mm min)L (230mm min)XL (230mm min)Same
Width:For S: 80±10mmFor M: 95±10 mmFor L: 110±10 mmFor XL: 120±10 mmPalm width:Small (80±10mm)Medium (95±10mm)Large (110±10mm)X large (120±10mm)
Physical Properties(ASTM D6319-19)Meets requirements of the ASTMD6319-19Before Aging:Tensile Strength: ≥14MpaUltimate Elongation: ≥500%Meets requirements of the ASTMD6319-19Before Aging:Tensile Strength: Min 14 MpaUltimate Elongation: Min 500%Same
Meets requirements of the ASTMD6319-19After Aging:Tensile Strength: ≥14MpaUltimate Elongation: ≥400%Meets requirements of the ASTMD6319-19After Aging:Tensile Strength: Min 14MpaUltimate Elongation: Min 400%
Thickness(ASTM D6319-19)Palm min. 0.05 mmFinger min. 0.05 mmPalm min. 0.05 mmFinger min. 0.05 mmSame
Powder Free(ASTM D6319-19)≤2 mg/glove≤2 mg/gloveSame
Elements ofComparisonSubject DevicePredicate DeviceResult
Freedom from Holes(Water Tight -1000 ml)-ASTM D6319-19(Cross Reference D5151)Meets requirements of the ASTMD6319-19Meets requirements of the ASTMD6319-19Same
Biocompatibility -Skin Sensitization(ISO 10993-10:2010)Under the conditions of the studynot a sensitizerUnder the conditions of the studynot a sensitizerSame
Biocompatibility -Skin Irritation (ISO10993-10:2010)Under the conditions of study notan irritantUnder the conditions of study notan irritantSame
Biocompatibility -Acute SystemicToxicity (ISO 10993-11: 2017)Cytotoxicity is assessed viarationale. Under the condition ofacute systemic toxicity test,the test article did not show acutesystemic toxicity in vivo.Cytotoxicity is assessed viarationale. Under the condition ofacute systemic toxicity test,the test article did not show acutesystemic toxicity in vivo.Same

{5}------------------------------------------------

{6}------------------------------------------------

Comparison in Detail(s):

Note:

Although the subject device has no texture, which is different from the predicate device, both the performance of the subject device and predicate device met the requirements of the standard ASTM D6319-19. So, the difference between the subject device and predicate device will not affect the safety and effectiveness.

8. Test Summary

8.1 Summary of Non-Clinical Performance Testing

1) Performance Testing Summary:

Test MethodTest PurposeAcceptanceCriteriaTest ResultsConclusion
ASMT D6319-19To determine theWidth:Lot Batch ofPassed
Standardwidth, length,For S: $80\pm10$ mm20210716A:
Specification forand thickness ofFor M: $95\pm10$ mmWidth:
Nitrile Examinationthe glovesFor L: $110\pm10$ mmFor S: 79~83mm
Gloves for MedicalFor XL: $120\pm10$ mmFor M: 93~97mm

{7}------------------------------------------------

Application -PhysicalDimensions TestLength:For S: ≥220mmFor M: ≥230mmFor L: ≥230mmFor XL: ≥230mmFor L: 101-105mmFor XL: 110mmLength:For S: 233237mmFor M: 233237mmFor L: 240244mmFor XL: 240244mmLot Batch of20210719A:Width:For S: 7983mmFor M: 9497mmFor L: 101-104mmFor XL: 110mmLength:For S: 234236mmFor M: 234237mmFor L: 240244mmFor XL: 240245mmLot Batch of20210721C:Width:For S: 8085mmFor M: 9498mmFor L: 105-109mmFor XL: 110mmLength:For S: 230235mmFor M: 235238mmFor L: 239243mmFor XL: 240243mmLot Batch of20210716A:For S/M/L/XL:Thickness:Finger: ≥0.05mmPalm: ≥0.05mm
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

{8}------------------------------------------------

Finger min: 0.12mmPalm min: 0.08mm
Lot Batch of20210719A:For S/M/L/XL:Finger min: 0.13mmPalm min: 0.08mm
Lot Batch of20210721C:For S/M/L/XL:Finger min: 0.13mmPalm min: 0.08mm
ASMT D6319-19StandardSpecification forNitrile ExaminationGloves for MedicalApplication -PhysicalDimensions TestTo determine thetensile strengthand ultimateelongationbefore and afteraccelerationagingBefore Aging:Tensile Strength:≥14MpaUltimate Elongation:≥500%After Aging:Tensile Strength:≥14MpaUltimate Elongation:≥400%For all three lots:Before Aging:Tensile Strength:≥14MpaUltimate Elongation:≥500%After Aging:Tensile Strength:≥14Mpa UltimateElongation: ≥400%Passed
ASTM D6319-19(ASTM D5151-11)Standard TestMethod forDetection of Holesin Medical GlovesTo determine theholes in theglovesAQL 2.5For all three lots:Pass at AQL 2.5Passed
ASMT D6319-19(ASTM D6124-11)Standard TestMethod forResidual Powderon Medical GlovesTo determine theresidual powderin the gloves< 2.0 mg/gloveLot Batch of20210716A:For S/M/L/XL: Pass at0.12 mg/gloveLot Batch ofPassed

{9}------------------------------------------------

20210719A:For S/M/L/XL: Pass at0.15 mg/gloveLot Batch of20210721C:For S/M/L/XL: Pass at0.21 mg/glove
--------------------------------------------------------------------------------------------------------------------------------------

2) Biocompatibility Testing Summary:

Test MethodTest PurposeAcceptanceCriteriaTest ResultsConclusion
ISO 10993-10Biological evaluationof medical devices -Part 10: Tests for skinirritation and skinsensitizationTo evaluate thepotentialintracutaneousreactivity caused byintracutaneously injectthe extract to rabbitsUnder theconditions of studynot an irritationUnder theconditions ofstudy not anirritationPassed
ISO 10993-10Biological evaluationof medical devices -Part 10: Tests for skinirritation and skinsensitizationTo determine the skinsensitization potentialin guinea pigs.Under theconditions of thestudy not asensitizationUnder theconditions of thestudy not asensitizationPassed
ISO 10993-11:2017Biological evaluationof medical devices -Part 11: Tests foracute systemic toxicityThe test item wasevaluated for acutesystemic toxicity inICR mouseUnder theconditions of thestudy no systemictoxicityUnder thecondition ofacute systemictoxicity test,the test articledid not showacute systemictoxicity in vivo.Passed

8.2 Summary of Clinical Performance Test

No clinical study is included in this submission.

{10}------------------------------------------------

9. Final Conclusion:

The subject device is a safe, as effective, and perform as well as or better than the legally marketed predicated K203593.

§ 880.6250 Non-powdered patient examination glove.

(a)
Identification. A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls). The device, when it is a finger cot, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.